We would love to hear your thoughts about our site and services, please take our survey here.
Wasn't someone saying the bottom was 3p?..... There is no point trying to ramp this anymore
This has been absolutely dreadful.
This seriously concerning me now. what exactly is the cause of this pathetic share price. We have literally just been given what should be huge news over in Ireland yet we're down over 5% today.
I'm very close to packing things in with thsi
FUN FACT: Roby used to be a music producer and DJ....
https://stockhead.com.au/health/mgc-pharma-to-commence-three-vital-clinical-trials-in-2021/
Price just jumped 0.20p, Watch this finish in red lol
(hopefully not though)
I am in this for the long run 100% but the short term really isn't looking bright. What is going on with the price? It looks like we're going back to the IPO price......
Here Here, I still can't smell or taste.....
Buy the rumour, sell the news.....
I'm not a de-ramper nor ramper. I will always look at it from both sides. With the situation we find ourselves in with the halt happening I'm just trying to judge if this is a good thing or not.
Personally, I think this may be good as ARTEMIC is a natural product. All ingredients are natural, nothing processed or man made (from what I can see). I can't see this being halted due to a bad reaction or red flags for it. Also it's completed 2 of the trials already. I think this may be positive just unsure how positive it is. Would be interested on what others think too.
Heeney,
Not trying to come across antagonistic but why 20p?
This was never going to be pumped by the reddit traders? This stock isn't like Tilray or any of weed those stocks. The price on this stock would have no effect if the reddit traders started to pump weed stocks lol
The acquisition provides MGC Pharma with a number of significant advantages such as reducing lead times for pre-clinical research, allowing it to better define clinical trial protocols and to build stronger relationships with regulators.
By increasing its throughput capability for medicines, and making clinical trial performance and design an in-house activity, the acquisition will deliver a host of advantages and cost savings.
MediCaNL generated revenue of $1m in 2020 and the business has a profit margin of 25 per cent.
The company is based in Israel and provides specialist services to the pharmaceutical sector for the development of new medicines including the provision of pre-clinical and clinical trial services.
It has 18 years of expertise in handling clinical trials and research management and research data from past studies of Phase I to IV clinical trials using a variety of treatment methods.
All of the trials MediCaNL will carry out for MGC Pharma will be to the most rigorous clinical standards in accordance with the European Medicines Agency, US Federal Drug Administration, ICH Good Clinical Practice, and Israeli health regulations.
100%, I'm all for it
I read in the article that they are paying this company with $6,000,000 worth of shares. That is also quite positive for us as this company must feel that they are going to be worth something in the future. Adds even more confidence for me in this company.
https://clinicaltrials.gov/ct2/show/NCT04802382
For those wondering.....^
Some more good press this morning from that article. Nice to see a push to the upside as well. I'm still yet to hear any negative news about this company moving forward (recently). Seems we're on right track with revenue as well as the getting products lined up for the next 5 years. Should be interesting!
I don’t really understand why you sound so defensive? I’m not deramping or making false statements. I’m simply just looking at it on the other side of the fence.....
What you trying to imply mazik?
Thanks for clearing that up guys. You learn something new everyday!
May well be a stupid question but I am asking it anyway. Why don't MGC just issue less shares or just buy them back as I know there are well over a billion shares. Surely they will make more money for the company and other projects that need funding if there is a high demand but less supply? Oh, and plus this would make existing traders happy :)
What was your aim of that comment?